a16z Bio+Health

What a16z Bio+Health does

a16z Bio+Health is Andreessen Horowitz's dedicated healthcare and biotechnology investment practice, operating as a focus area within the larger Andreessen Horowitz (a16z) venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz and headquartered in Menlo Park, California. The practice deploys venture capital into early- to growth-stage companies across biotechnology, therapeutics, healthcare technology, and health services, sourcing deals through direct outreach, the broader a16z portfolio network, content platforms, and dedicated founder programs. Its customer base consists of bio and health technology startup founders seeking sector-specific capital and strategic support.

a16z Bio+Health does not offer standalone software products; its "platform" consists of capital plus non-cash support delivered through three dedicated founder programs — Bio Builders, Health Builders, and Digital Health Builders — alongside a content and podcast infrastructure that includes the Raising Health show and editorial coverage of AI in Bio+Health, therapeutics development, and consumer health. The practice positions itself as providing sector-specific expertise on regulatory, clinical, and commercial pathways, supplemented by the network effects of the broader a16z ecosystem spanning AI, Consumer, Crypto, Enterprise, Fintech, and Infrastructure.

The business model follows standard venture capital mechanics — management fees on committed capital plus carried interest on portfolio exits — though standalone revenue, fund size, and AUM figures are not publicly disclosed. Deal flow is generated through direct founder engagement, content-led top-of-funnel presence, and program-driven community building. The single named deal activity in the input is the co-lead of Stipple Bio Inc.'s $100M Series A in April 2026 alongside RA Capital and Nextech Invest, with GV, Emerson Collective Investments, Lola Capital Partners, and GordonMD Global Investments participating as existing investors.

Name

a16z Bio+Health

Legal name

Andreessen Horowitz

Website

https://a16z.com

Company type

Private

Founded year

2009

Operating status

Operating

Short description

a16z Bio+Health is Andreessen Horowitz's dedicated biotechnology and healthcare investment practice, deploying venture capital into early- and growth-stage therapeutics, digital health, and health technology companies, supporting portfolio founders through sector-specific programs, networks, and content platforms including the Raising Health podcast.

Ownership category

akta.pro rank

Product category

Venture Capital / Biotech Investment

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

Keywords

• Venture capital investment
• Biotech investment fund
• Healthcare venture capital
• Life sciences funding
• Digital health investing

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Distribution channels1 record

Marketing channels5 records

Core offering

a16z Bio+Health is Andreessen Horowitz's dedicated investment arm for biotech and healthcare. The firm deploys venture capital into early to growth-stage biotechnology, healthcare technology, therapeutics, and health services companies, while also providing strategic guidance, operational support, and access to a network of portfolio companies and industry experts.

Product overview

a16z Bio+Health is a specialized investment practice within Andreessen Horowitz focused on biotechnology and healthcare startups. The practice provides venture capital funding and strategic support to early-stage companies developing novel therapeutics, digital health technologies, and healthcare innovations. As an investment fund rather than a product company, a16z Bio+Health does not offer standalone software products or services. The firm operates various content and community programs including Bio Builders, Digital Health Builders, Health Builders, and maintains a Bio + Healthcare podcast network covering AI in bio/health, therapeutic development, and healthcare innovation.

Differentiator

Problem solved

Functional benefit

Brands

• Bio Builders: Program for biotechnology founders and entrepreneurs
• Health Builders
• Digital Health Builders
• Bio + Health

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves5 records

Expansion highlights4 records

Market position

Competitive moat5 records

Key risks4 records

Key highlights5 records

Customer concentration

• Xtwitter.com/a16z
• YouTubeyoutube.com/@a16z
• Facebookfacebook.com/andreessenhorowitz
• LinkedInlinkedin.com/company/a16z-bio-health
• Instagraminstagram.com/a16z

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about a16z Bio+Health